Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Stip

Showing results (231-240 of 278) with videos related to

Pageof 28
Sort By:
Cognitive Neuropsychiatry|April 25, 2007
Intrusion errors in explicit memory: their differential relationship with clinical and social outcome in chronic schizophreniaEmmanuel Stip, Marc Corbière, Luc J Boulay, et al.
Brain and Cognition|May 26, 2005
CANTAB explicit memory is less impaired in addicted schizophrenia patientsStéphane Potvin, Catherine Briand, Antoinette Prouteau, et al.
Attention Deficit and Hyperactivity Disorders|September 19, 2018
Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatrySmadar Valérie Tourjman, Stéphane Potvin, Fernando Corbalan, et al.
Journal of Psychiatric Research|December 21, 2007
Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitizationStéphane Potvin, Emmanuel Stip, Adrien Tempier, et al.
Schizophrenia Research|July 3, 2013
Redevelopment of tertiary psychiatric services in British Columbia: a prospective study of clinical, social, and residential outcomes of former long-stay inpatientsKaren L Petersen, Tonia L Nicholls, David Groden, et al.
Asian Journal of Psychiatry|January 8, 2021
When should psychiatrists think of anti-NMDA receptor encephalitis? A systematic approach in clinical reasoningKarim Abdel Aziz, Amna AlSuwaidi, Abeer Al-Ammari, et al.
Clinical Neuropharmacology|March 7, 2006
Somatic augmentation strategies in clozapine resistance--what facts?Constantin Tranulis, Fayçal Mouaffak, Laurent Chouchana, et al.
Schizophrenia Research|June 12, 2017
Multisite generalizability of schizophrenia diagnosis classification based on functional brain connectivityPierre Orban, Christian Dansereau, Laurence Desbois, et al.
Psychiatry Research|March 8, 2007
Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry studyStéphane Potvin, Adham Mancini-Marïe, Chérine Fahim, et al.
Frontiers in Psychiatry|October 12, 2012
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of SchizophreniaJoëlle Desfossés, Emmanuel Stip, Lahcen Ait Bentaleb, et al.
Pageof 28

Showing results (231-240 of 278) with videos related to

Sort By:
Pageof 28
Cognitive Neuropsychiatry|April 25, 2007
Intrusion errors in explicit memory: their differential relationship with clinical and social outcome in chronic schizophreniaEmmanuel Stip, Marc Corbière, Luc J Boulay, et al.
Brain and Cognition|May 26, 2005
CANTAB explicit memory is less impaired in addicted schizophrenia patientsStéphane Potvin, Catherine Briand, Antoinette Prouteau, et al.
Attention Deficit and Hyperactivity Disorders|September 19, 2018
Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatrySmadar Valérie Tourjman, Stéphane Potvin, Fernando Corbalan, et al.
Journal of Psychiatric Research|December 21, 2007
Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitizationStéphane Potvin, Emmanuel Stip, Adrien Tempier, et al.
Schizophrenia Research|July 3, 2013
Redevelopment of tertiary psychiatric services in British Columbia: a prospective study of clinical, social, and residential outcomes of former long-stay inpatientsKaren L Petersen, Tonia L Nicholls, David Groden, et al.
Asian Journal of Psychiatry|January 8, 2021
When should psychiatrists think of anti-NMDA receptor encephalitis? A systematic approach in clinical reasoningKarim Abdel Aziz, Amna AlSuwaidi, Abeer Al-Ammari, et al.
Clinical Neuropharmacology|March 7, 2006
Somatic augmentation strategies in clozapine resistance--what facts?Constantin Tranulis, Fayçal Mouaffak, Laurent Chouchana, et al.
Schizophrenia Research|June 12, 2017
Multisite generalizability of schizophrenia diagnosis classification based on functional brain connectivityPierre Orban, Christian Dansereau, Laurence Desbois, et al.
Psychiatry Research|March 8, 2007
Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry studyStéphane Potvin, Adham Mancini-Marïe, Chérine Fahim, et al.
Frontiers in Psychiatry|October 12, 2012
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of SchizophreniaJoëlle Desfossés, Emmanuel Stip, Lahcen Ait Bentaleb, et al.
Pageof 28